Uses home blood pressure readings to adjust medicines for uncontrolled high blood pressure

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with high blood pressure that is not well controlled. It tests adjusting blood pressure medicine using readings taken at home.

Age

18 to 85 years

Sex

All sexes can join.

Disease stage

Diagnosed hypertension (high blood pressure) with a reading above 150/95.

Main reasons for not taking part

• Pregnancy
• Stage 5 chronic kidney disease
• End Stage Renal Disease
• Enrolled in hospice care

The registry criteria, word for word

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

• Are you between 18 and 85 years old?YesNo

What the trial wants to find out

The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.

The group in the trial

• IN-HOME BP: titrating BP medications based on patient-recorded home blood pressure readings

  This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.

  Treatment: IN-HOME BP